Treatment of Breast and Lung Cancer Cells with a N-7 Benzyl Guanosine Monophosphate Tryptamine Phosphoramidate Pronucleotide (4Ei-1) Results in Chemosensitization to Gemcitabine and Induced eIF4E Proteasomal Degradation

2013

Treatment of Breast and Lung Cancer Cells with a N-7 Benzyl Guanosine Monophosphate Tryptamine Phosphoramidate Pronucleotide (4Ei-1) Results in Chemosensitization to Gemcitabine and Induced eIF4E Proteasomal Degradation
Molecular Pharmaceutics (2013)

The articles on our website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice. The views and opinions expressed in this article are those of the author(s) and do not necessarily reflect the views or official position of Robins Kaplan LLP.

Disclaimer

Shui Li

Associate

Related Publications

Summer 2020
The Brave New World of Virtual Notarization
Steven Orloff, Manleen Singh - The Robins Kaplan Spotlight, Vol. 5, No. 2
Summer 2020
What Could be the Harm? Minnesota's Harmless Error Statute
Matthew Frerichs, Ena Kovacevic - The Robins Kaplan Spotlight, Vol. 5, No. 2
Summer 2020
What's a Fiduciary To Do? Considerations for Periods of Uncertainty
Anthony Froio, Denise Rahne - The Robins Kaplan Spotlight, Vol. 5, No. 2
June 17, 2020
Big Data in the Wake of Covid-19—A Conundrum for Enforcers
Meegan Hollywood, Adam Mendel - Bloomberg Law
June 2020
Trade Secrets: Safe as Houses
Christopher Larus, David Prange, Alyssa Bixby-Lawson - Intellectual Property Magazine
Back to Top